Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
42 participants
INTERVENTIONAL
2016-10-31
2017-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Effect of tES on a Cognitive Training
NCT03475446
Effects of Individualized Theta-tACS on a Working Memory Training at SCD
NCT06501755
tES Effects on Associative Memory Performance
NCT03351452
Network-targeted Theta-burst Stimulation for Episodic Memory Improvement in Mild Cognitive Impairment
NCT04558164
Stimulation to Improve Memory
NCT03875326
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Tolerability and blinding will also be evaluated using standard side effect questionnaires.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
DOUBLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Active HD-tDCS
Participants will receive "real" HD-tDCS (3 milliamps for 20 minutes) for a single session.
Active HD-tDCS
Participants will receive active HD-tDCS at 3mA for 20 minutes
Sham HD-tDCS
Participants will undergo the exact same procedures as the active group but will receive sham stimulation for a single session.
Sham HD-tDCS
Participants will receive sham HD-tDCS
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Active HD-tDCS
Participants will receive active HD-tDCS at 3mA for 20 minutes
Sham HD-tDCS
Participants will receive sham HD-tDCS
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Participants will be age 50 or older.
Exclusion Criteria
2. A history of serious mental illness (e.g., bipolar disorder, schizophrenia, axis 2 disorders)
3. Sensory or motor impairments that limit the ability to take part in the study
4. A significant history or current use of alcohol or drug abuse/dependence
5. Those who are currently pregnant (if there is a question of pregnancy, pregnancy tests will be available for participants at no charge)
6. Participants with an Mini Mental State Examination score \<24 at screening.
50 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Michigan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Benjamin Hampstead, PhD
Associate Professor
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Benjamin M Hampstead, PhD
Role: PRINCIPAL_INVESTIGATOR
University of Michigan
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
University of Michigan - Department of Psychiatry
Ann Arbor, Michigan, United States
Countries
Review the countries where the study has at least one active or historical site.
References
Explore related publications, articles, or registry entries linked to this study.
Brunoni AR, Amadera J, Berbel B, Volz MS, Rizzerio BG, Fregni F. A systematic review on reporting and assessment of adverse effects associated with transcranial direct current stimulation. Int J Neuropsychopharmacol. 2011 Sep;14(8):1133-45. doi: 10.1017/S1461145710001690. Epub 2011 Feb 15.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
HUM00111090.1 PCN
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.